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Abstract
Background: Patients with diabetes mellitus (DM) have high risk of heart failure. Whether some of the risk is
directly linked to metabolic derangements in the myocardium or whether the risk is primarily caused by coronary
artery disease (CAD) and hypertension is incompletely understood. Echocardiographic tissue Doppler imaging was
therefore performed in DM patients without significant CAD to examine whether DM per se influenced cardiac
function.
Methods: Patients with a left ventricular (LV) ejection fraction (EF) > 35% and without significant CAD, prior
myocardial infarction, cardiac pacemaker, atrial fibrillation, or significant valve disease were identified from a tertiary
invasive center register. DM patients were matched with controls on age, gender and presence of hypertension.
Results: In total 31 patients with diabetes and 31 controls were included. Mean age was 58 ± 12 years, mean LVEF
was 51 ± 7%, and 48% were women. No significant differences were found in LVEF, left atrial end systolic volume,
or left ventricular dimensions. The global longitudinal strain was significantly reduced in patients with DM (15.9 ±
2.9 vs. 17.7 ± 2.9, p = 0.03), as were peak longitudinal systolic (S’) and early diastolic (E’) velocities (5.7 ± 1.1 vs. 6.4
± 1.1 cm/s, p = 0.02 and 6.1 ± 1.7 vs. 7.7 ± 2.0 cm/s, p = 0.002). In multivariable regression analyses, DM remained
significantly associated with impairments of S’ and E’, respectively.
Conclusion: In patients without significant CAD, DM is associated with an impaired systolic longitudinal LV
function and global diastolic dysfunction. These abnormalities are likely to be markers of adverse prognosis.
Introduction
Patients with diabetes mellitus (DM) have an increased
risk of developing heart failure compared to patients
without DM[1,2]. Whether this increased risk is solely
based on coronary artery disease (CAD) and hyperten-
sion, or whether some of the risk might be explained by
a direct influence of DM on cardiac function (diabetic
cardiomyopathy) is incompletely understood.
Diabetic cardiomyopathy has been defined as the pre-
sence of myocardial abnormalities in the absence of cor-
onary artery disease, hypertension or other significant
etiology[3]. Several experimental studies have identified
changes consistent with diabetic cardiomyopathy,
including microangiopathy, metabolic disturbances and
myocardial fibrosis[4]. The evidence of a clinical impact
of diabetic cardiomyopathy on myocardial function has
increased in recent years, mainly because of refined
echocardiographic methods such as tissue Doppler tech-
niques. In a large population-based study, tissue Doppler
imaging revealed impaired systolic and diastolic function
in persons with DM[5], and several other observational
studies of populations without any apparent heart dis-
eases have found similar results[6-9]. However, to our
knowledge, no previous study has specifically examined
the influence of DM in patients where coronary angio-
graphy (CAG) was used to rule out the presence of sig-
nificant CAD. The aim of the present study was
therefore to assess myocardial function by echocardio-
graphic tissue Doppler in a series of DM patientsDepartment of Cardiology, Gentofte Hospital, University of Copenhagen,
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Since the middle of 2005, all echocardiography examina-
tions performed at Gentofte University Hospital were
digitally stored on a central server. All the echocardio-
grahic examinations were performed by dedicated physi-
cians and specially trained nurses, and the majorities of
available investigations were conducted according to a
standardized protocol. The hospital also functions as a
tertiary invasive center, and since 1999, data on consecu-
tive coronary artery catheterizations were registered in a
central database. The database held information on CAD
risk profile, co-morbidities, and information on the
angiography procedure and coronary pathology. For the
present study, all patients with DM but without signifi-
cant CAD (i.e., absence of > 50% diameter stenosis in any
coronary vessel ≥ 1.5 mm in diameter) examined between
the middle of 2005 and the middle of 2009 were identi-
fied from the catheterization register. As per the standard
CAG database protocol at the institution, the CAG diag-
nosis for patients in the present study included patients
with ‘diffuse coronary artery disease, no significant ste-
noses’ or ‘no coronary artery disease’, respectively.
Patients with significant valve disease, cardiac pacemaker,
prior myocardial infarction, atrial fibrillation, or left ven-
tricular ejection fraction (LVEF) <35%, respectively, were
excluded. Individual patient data were then linked to the
echocardiographic database. Controls comprised patients
without DM, subjected to the aforementioned exclusion
criteria. Each case was matched with one control on age
(± 3 years, highest priority), gender (second highest prior-
ity), and presence of hypertension (third highest priority),
by using a computerized selection algoritm (the Greedy
macro by Lori S. Parsons, accessed January 1, 2009 at
http://www2.sas.com/proceedings/sugi26/p214-26.pdf).
The median time difference between the CAG investi-
gation and the echocardiogram record was 0 days with
the inter quartile range being -1 to 43 days. Totally 56%
of the echocardiograms were performed prior to CAG
investigation (median time 1 day prior to CAG) and
44% of the echocardiograms were performed after CAG
(median time 48 days). Among those having a CAG per-
formed prior to echocardiography, the time delay
between the two investigations was generally at most
three months, but a few patients (n = 6; 4 cases and 2
controls) with longer time intervals were included
(range 95 to 564 days), as it was assured from the cathe-
terization register that no upcoming ischemic events
were registered in the mean time. There was no differ-
ence in investigational time discrepancy between
patients with DM and controls.
Echocardiographic analyses
Echocardiograms were obtained using GE Vivid 7 ultra-
sound system. All echocardiograms were analyzed by
one single investigator (CA) using Echopac ‘08 software
(GE Medical Systems, Norway).
Conventional measurements
Left ventricular end diastolic dimensions (interventricu-
lar septum wall thickness, end diastolic inner diameter
and posterior wall thickness) were obtained from the
parasternal long axis view. Biplane LVEF was estimated
using Simpson’s method and a LVEF ≥50% was consid-
ered to be preserved. Left atrial end systolic dimensions
were estimated from the apical four - and two chamber
views.
The diastolic function was classified from measure-
ments of color M-mode and tissue Doppler, according
to the criteria accepted by the Canadian Consensus on
Diastolic Dysfunction[10].
Tissue Doppler imaging derived measurements
Mitral basal left ventricular velocities (longitudinal peak
velocities) were obtained from two dimensional color-
coded tissue Doppler image loops (offline measure-
ments). The peak systolic (S’), early diastolic (E’) and
atrial (A’) tissue velocities were measured in the basal
segments, immediately apical to the mitral annulus. The
presented values are the mean values from both sides of
three apical views (i.e. four chamber, two chamber and
apical long axis views).
Average global left ventricular longitudinal strain
Global left ventricular longitudinal strain was quantified
using the Automated Function Imaging (AFI), which
was based on two dimensional strain imaging. The soft-
ware package worked by tracking speckles (acoustic
markers), and by the use of frame-to-frame changes of
the speckles, motion and velocity (and thereby maximal
longitudinal systolic shortening fraction) was derived.
The presented values are the average from all the three
apical views.
Intra and inter observer variation
From the echocardiography database we randomly
selected 25 patients for inter and intra observer varia-
tion analyses. Intra observer variation was as follow
(median [5 th;95 th percentiles]): LVEF 4.8% (0;24.1); S’
1.1% (0.3;9.7); E’ 0.8% (0.2;5.2); A’ 1.7% (0.3;19.6); AFI
2.2% (0.3;5.9). Corresponding inter observer variation
was: LVEF 4.4% (0.9;57.7); S’ 2.8% (0.0;14.6); E’ 2.2%
(0.2;17.2); A’ 2.7% (0.4;19.2); AFI 4.3% (0.4;17.2). Bland-
Altman plots revealed no signs of skewed distributed
variances.
Data analysis
Continuous variables were compared with t-test and dis-
crete variables with chi square test. General linear mod-
els were used to investigate the influence of several
factors on the peak tissue velocities where the model
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assumptions were fulfilled (linearity of continuous vari-
ables, homogeneity and normally distributed residuals
and no interactions). All calculations were performed
using SAS version 9.1 (SAS institute, Cary, North Caro-
lina). The level of statistical significance was set at a p-
value < 0.05. No statistical adjustment was made for the
number of comparisons performed.
Ethics
The study was approved by the Danish Data Protection
Agency (No. 2007-41-1667). Retrospective register based
studies do not need ethical approval in Denmark.
Results
In total 2388 patients were identified from the coronary
artery intervention database with a diagnosis of no sig-
nificant coronary artery disease/diffuse coronary artery
disease without significant stenoses. Of these, 333 had
diabetes, no prior myocardial infarction, no pacemaker,
no congenital heart disease, and no significant valve dis-
ease registered. After matching with the echocardio-
graphic database, 89 remained. Of these, 31 had
sufficient investigations for inclusion in the study. Main
reasons for exclusions were: lack of correlation between
CAG and echocardiogram investigations; atrial fibrilla-
tion; bundle branch block; and investigations without
tissue Doppler records.
The characteristics of the 31 patients with diabetes
and 31 controls included in analyses are presented in
Table 1. Patients with diabetes had a higher prevalence
of dyslipidaemia, a higher prevalence of hypertension
(despite attempts at matching for hypertension) and a
higher BMI, compared to patients without diabetes.
Notably, no significant differences were found in LVEF,
left atrial end systolic volume, or prevalence of diastolic
dysfunction between patients with and without diabetes.
Mitral E/E’ ratio was significantly higher among patients
with DM (9.9 ± 5.8 vs. 7.0 ± 1.6, p = 0.01) and global
longitudinal strain was significantly lower in patients
with DM (15.9 ± 2.9% vs. 17.7 ± 2.9%, p = 0.03), com-
pared to controls.
Tissue Doppler derived peak myocardial velocities and
diabetes
Figure 1 illustrates the peak longitudinal systolic, early
diastolic and atrial tissue velocities in patients with and
without DM. Mean S’ and E’ were significantly lower in
patients with DM, compared to controls (5.7 ± 1.1 vs. 6.4
± 1.1 cm/s, p = 0.02 and 6.1 ± 1.7 vs. 7.7 ± 2.0 cm/s, p =
0.002).
Adjusted for multiple variables, DM remained asso-
ciated with impairments in peak tissue velocities and E/
E’ ratio, as shown in Table 2. The presence of hyperten-
sion was not found to modify the impairments of S’, E’,
A’, or E/E’ ratio associated with DM (p for interactions
> 0.3 in all analyses).
By calculating the relative difference between patients
with and without DM, the diastolic function measured
by E’ was shown to be the relatively most impaired of
these parameters. Mean E’ velocity in DM patients was
only 79% of values of the control group. Correspond-
ingly, mean S’ and A’ in patients with DM were 89%
and 99% of the mean values of controls.
Sensitivity analyses
Since the prevalence of hypertension was found to be
higher among patients with DM, compared to controls
(despite the attempted matching procedure), we per-
formed a subgroup analysis based only on matched
pairs (n = 46). These analyses showed similar results as
the main study: Mean S’, E’ and A’ were 5.9 ± 1.8 m/s,
5.4 ± 1.1 m/s and 6.3 ± 1.7 m/s in patients with DM,
compared to 6.5 ± 1.2 m/s, 7.7 ± 2.0 m/s and 7.2 ± 1.8
m/s in controls, p for differences <0.001, <0.001 and 0.1,
respectively.
Discussion
The present study demonstrated that patients with DM,
but without significant CAD had a reduced peak systolic
and early diastolic tissue velocity as well as a reduced
global longitudinal strain, compared to patients without
DM. These impairments in systolic and diastolic func-
tion were not identifiable in any of the conventional
echocardiographic parameters. Since all echocardio-
grams were obtained as a regular clinical procedure, the
results of the present study are directly applicable to
everyday clinical practice. To our knowledge, this is the
first study investigating tissue Doppler parameters in
relation to DM in patients and absence of significant
CAD at CAG.
Our findings support the results from several other
studies, which have found DM to be associated with
impairments in systolic and diastolic function despite
absence of overt heart disease[6,7,9,11,12]. Estimated by
the relative difference in mean tissue Doppler longitudi-
nal peak velocities and compared to controls, the diasto-
lic function was shown to be more impaired than the
systolic function in patients with DM. This finding is in
accordance with the hypotheses of increased myocardial
stiffness, increased resting myocyte tension and deposi-
tion of advanced glycated end products associated with
diabetic cardiomyopathy[13]. Furthermore, myocardial
steatosis, as seen in type 2 DM patients, has shown to
be an independent predictor of diastolic dysfunction[14].
Because ischemia is known to initially affect the diastolic
parameters[15], the observed differences could also be
due to coronary microangiopathy or small vessel disease.
Previous work has also demonstrated that in patients
with diffuse CAD without focal stenosis at CAG, the dif-
fuse disease process can lead to a significant continuous
pressure fall along the epicardial coronary arteries, i.e.,
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the functional equivalent of a stenosis[16]. Although
there was no difference in prevalence of ‘diffuse coron-
ary artery disease, no significant stenoses’ vs. ‘no coron-
ary artery disease’ between patients with DM and
controls, increased prevalence of atherosclerosis in
patients with DM may have contributed to our findings,
since these CAG diagnoses were rather subjective and
ill-defined.
The presence of hypertension has previously been
shown to potentiate the impairments in the diastolic
function associated with DM[17]. However, the present
study could not confirm these findings (no interaction
was found between DM and hypertension). It is possible
that our study population was too small to detect these
changes, or that the hypertensive patients included in
this study were pharmacologically sufficiently regulated
to negate such effects.
In a clinical context, the subclinical impairments of
left ventricular function in patients with DM are recog-
nized to carry an adverse prognosis[18]. Therefore, the
Table 1 Population characteristics:
Diabetes: No diabetes: p for difference:
n = 31 n = 31
Age (years) 58 (± 12) 58 (± 12) 0.9
Gender, male 52% 52% 1.0
BMI (kg/m 2) 29 (± 5) 25 (± 3) <0.001
Current smoker 20% 32% 0.2
Previous smoker 45% 39% 0.6
Hypertension 71% 45% 0.03
Hypercholesterolaemia 84% 26% <0.0001
Family history of ischemic heart disease 48% 61% 0.3
Antidiabetic medications:
Insulin 35% -
Oral anti-diabetic medication 39% -
Diet 13% -
No treatment 13% -
Coronary angiography:
Diffuse coronary disease, no significant stenoses 35% 29% 0.6
No coronary artery disease 65% 71% 0.6
Final diagnosis based on coronary angiography:
Angina pectoris (I20.) 55% 42% 0.3
Investigation for suspect heart disease (Z03.5) 45% 58% 0.3
Conventional echocardiography parameters:
Left ventricular ejection fraction (%) 49 (± 7) 52 (± 7) 0.1
Proportion of patients with an LVEF ≥50% 52% 55% 0.8
Left atrial end systolic volume (ml) 35 (± 14) 42 (± 20) 0.1
Mitral E/E’ ratio 9.9 (± 5.8) 7.0 (± 1.6) 0.01
Left ventricular dimensions:
Interventricular septum thickness, end diastolic (mm) 1.1 (± 0.2) 1.1 (± 0.3) 0.5
Interventricular diamenter, end diastolic (mm) 4.8 (± 0.8) 4.7 (± 0.6) 0.3
Posterior wall thickness, end diastolic (mm) 1.0 (± 0.2) 1.0 (± 0.1) 0.8
Classification of diastolic function *: overall trend test p = 0.2
Normal 55% 75% 0.1
Diastolic dysfunction I 32% 16% 0.1
Diastolic dysfunction II 10% 3% 0.3
Diastolic dysfunction III 0% 0% -
Tissue Doppler parameters:
Peak longitudinal systolic velocity, S’ (cm/s) 5.7 (± 1.1) 6.4 (± 1.1) 0.02
Peak longitudinal early diastolic velocity, E’ (cm/s) 6.1 (± 1.7) 7.7 (± 2.0) 0.002
Peak longitudinal atrial velocity, A’ (cm/s) 6.8 (± 1.9) 6.9 (± 1.7) 0.8
Average global longitudinal strain, AFI (%) 15.9 (± 2.9) 17.7 (± 2.9) 0.03
Continuous variables are presented as mean (± standard deviation) and discrete variables are presented as percentage. * = In concordance with[10].
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results from the present study further emphasize that
patients with DM should continuously be regarded as a
high risk group, even when CAG and conventional
echocardiography investigations appear normal.
Limitations of the study
All analyses were performed from existing echocardio-
gram records, which is associated with some
limitations. Firstly, some patients had an echocardio-
graphy investigation carried out after CAG. Thus,
there was a risk of including patients with a clinically
silent but significant coronary stenosis developing in
the period between CAG and echocardiogram,
although no such events were recorded in the catheter-
ization register. Secondly, patients with DM had a
higher prevalence of hypertension despite our
attempted matching of controls for this variable. It is
not unexpected, however, that hypertension was more
prevalent in patients with DM and basically it may be
impossible to provide perfect matches for these
patients. Thirdly, the AFI measurements were lacking
in totally 12 patients (5 patients with DM and 7 con-
trols), mainly because echocardiograms were recorded
with too low frame rates, or with different heart rates
in the three apical views. Therefore, AFI results were
not subjected to multivariable analysis, which other-
wise could have been interesting. The lack of data on
HbA1c and other biochemistry parameters, diabetes
duration and detailed data on medical therapies was
also a limitation of the study.
Conclusions
Patients with DM and absence of significant CAD at
CAG have impaired systolic longitudinal left ventricular
function and a global diastolic dysfunction, which is
likely to be associated with an adverse prognosis.
Figure 1 Individual plot of mean peak systolic (S’), early
diastolic (E’) and atrial (A’) velocities according to diabetes
(DM) status. All values are measured from the three apical views at
both sides of the mitral annulus level (in total six segments).











6.4 (± 0.2) <0.0001 7.6 (± 0.3) <0.0001 6.9 (± 0.3) <0.0001 7.0 (± 0.8) <0.0001
Diabetes -0.7 (± 0.3) 0.01 -1.4 (± 0.5) 0.004 0.1 (± 0.5) 0.8 2.9 (± 1.1) 0.02




8.0 (± 1.3) <0.0001 15.6 (± 1.6) <0.0001 5.3 (± 2.0) 0.01 -2.9 (± 4.8) 0.6
Diabetes -0.7 (± 0.3) 0.04 -1.3 (± 0.4) 0.003 0.2 (± 0.5) 0.6 2.8 (± 1.2) 0.02
Age (per 10 years
increments)
-0.2 (± 0.2) 0.1 -1.2 (± 0.2) <0.0001 0.3 (± 0.2) 0.2 1.6 (± 0.6) 0.01
Gender, male -0.02 (± 0.3) 0.9 -0.8 (± 0.4) 0.06 0.7 (± 0.5) 0.2 0.1 (± 1.1) 0.9







0.04 (± 0.04) 0.9 0.09 (± 0.4) 0.8 0.6 (± 0.5) 0.2 -1.9 (± 1.1) 0.09
BMI (per 1 kg/m2
increments)
0.05 (± 0.05) 0.8 0.03 (± 0.05) 0.5 0.04 (± 0.06) 0.5 0.05 (± 0.1) 0.7
R-Square: 0.15 0.55 0.17 0.29
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